We’ve compiled the most frequently asked questions from pet owners about canine tumor immunotherapy. This guide walks you through the key information step by step, covering the treatment’s mechanism, efficacy, potential side effects, and how to choose the right approach.



| Item | Immunotherapy | Chemotherapy | Radiation therapy |
|---|---|---|---|
| Mechanism of action | Attacks cancer cells by activating the immune system | Inhibits cell division | Damages cells with radiation |
| Severity of side effects | Generally mild, but rarely can be severe | Serious gastrointestinal upset, hair loss | Dermatitis, fatigue |
| Recurrence-prevention effect | Possible (forms immune memory, varies by tumor) | Moderate | Low |
| Treatment duration | Conducted regularly over several months | 1–2 times per week, for 3–6 weeks | Once daily, for 2–4 weeks |
Immunotherapy can form immune memory and lower the risk of recurrence in some tumors, but not all tumors respond, and it is usually combined with other treatments.

Signs That Require Immediate Veterinary Attention
If severe diarrhea, difficulty breathing, fever, or complete loss of appetite occurs during immunotherapy, visit the clinic immediately. These symptoms may indicate an excessively strong immune response, requiring prompt veterinary intervention.



A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Mason, N. and Dow, S. (2011) Therapeutic Strategies in Veterinary Oncology. Wiley-Blackwell.
[2] Burton, J.H. et al. (2011) Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. Journal of Veterinary Internal Medicine, 25(4), 920–926.
[3] Alemany, R. et al. (2022) Systemic cellular viroimmunotherapy for canine high-grade gliomas. Journal for Immunotherapy of Cancer, 10(12), e005669.